Herman Verrelst
InvestorFounding Partner & Senior Advisor at Heran Partners
Leuven, Flemish Region, Belgium
About
Herman Verrelst is a serial entrepreneur with over 25 years in high-tech companies. He founded and exited several University of Leuven spin-offs, including Cartagenia, which was acquired by Agilent, after which he led Agilent's Genomics & Clinical Applications division in California. He later served as CEO of Biocartis, a molecular diagnostics company focused on personalized medicine.
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Experience
- GynaiaExecutive Chairmancurrent2025 — present
- Aspect AnalyticsChairpersoncurrent2025 — present
- Aspect AnalyticsBoard Member2025
- Aspect AnalyticsExecutive Chair2023 — 2024
- nuclivisionBoard Membercurrent2025 — present
- HERAN PartnersFounding Partnercurrent2020 — present
- BioviaBoard Membercurrent2025 — present
- BiocartisChairman2023 — 2025
- BiocartisExecutive Chairman2023
- BiocartisChief Executive Officer2017 — 2023
- MedviaChairman of the Board2021 — 2025
- Ellison Institute of Technology OxfordChief Business Officer2024Oxford, England, United Kingdom
- icoMetrixBoard Member2013 — 2024
- flanders.bioBoard Member2018 — 2022
- FOx BiosystemsBoard Member2019 — 2020
- UgenTecBoard Member2015 — 2018
- Agilent TechnologiesVP and General Manager - Genomics and Clinical Application division2015 — 2017Santa Clara, California
- Agilent TechnologiesGeneral Manager - Clinical Applications Division2015
- CartageniaChief Executive Officer2011 — 2015
- CartageniaManaging Director2008 — 2011
Education
- KU LeuvenMaster in Engineering1991 — 2000
- Stanford University Graduate School of BusinessLeading Change and Organizational Renewal2005
Skills & more
Start-ups40Lifesciences11Entrepreneurship26Biotechnology12Business Development6Business Strategy17Venture Capital7Due Diligence2Healthcare2Data Analysis1Mergers & Acquisitions3Private Equity3
+5 more
Molecular BiologyLife SciencesAnalysisManagementStrategyFrom Herman's professional profile.
Same school
Also attended KU Leuven149
Katrin GeyskensExecutive Director at Capricorn Venture PartnersSimon WoutersInvestment Manager at Capricorn Venture PartnersWouter Van de PutteInvestment Director at Capricorn Venture PartnersFilip PintelonInvestment Partner Health at Capricorn Venture PartnersKim De KeyserValuation Expert at Capricorn Venture PartnersIne JordensLegal Director at Capricorn Venture Partners
+ 143 more
Also attended Stanford University Graduate School of Business1,231
Roelof BothaAdvisor & former Steward at Sequoia Capital; SpaceX board memberPeter FentonGeneral Partner at BenchmarkSteve JurvetsonCo-founder of Future VenturesDavid SzeAdvisory Partner at GreylockKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Hunter WalkCo-founder & Partner at Homebrew
+ 1,225 more
Shared employers
Also worked at Biovia1
Also worked at FOx Biosystems2
Also worked at ParticipatieMaatschappij Vlaanderen6
Also worked at Nobel Biocare2
)
Colleagues at Heran Partners
Annie Vereecken
Founding Partner & Senior Advisor at Heran Partners
Emke Goijens
Operations & Communications at Heran Partners
Flore Belmans
Analyst at Heran Partners
Geoffrey D'hondt
Investment Director at Heran Partners
Joris Mortelmans
Partner & Senior Advisor at Heran Partners
Katleen Vandersmissen
Managing Partner at Heran Partners
Laurens de Vries
Analyst at Heran Partners
Margot Huysmans
Analyst at Heran Partners